Please use this identifier to cite or link to this item:
Title: Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
Austin Authors: Levidiotis, Vicki;Freeman, Craig;Tikellis, Christos;Cooper, Mark E;Power, David Anthony
Affiliation: Austin Research Institute, Department of Nephrology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 1-Apr-2005
Publication information: Nephrology; 10(2): 167-73
Abstract: The beta-d-endoglycosidase, heparanase, is emerging as an important contributor to the pathogenesis of proteinuria. The purpose of the present study therefore was to examine the role of heparanase in a model of accelerated anti-glomerular basement disease (anti-GBM).Accelerated anti-GBM disease was induced and animals sacrificed at day 10 to establish heparanase expression using immunohistochemistry and western blot analysis. In addition, cortex was isolated from normal and diseased glomeruli to determine if mRNA levels altered with disease. A previously validated anti-heparanase antibody associated with proteinuria reduction, in a model of membranous nephropathy, was administered prior to disease induction to establish its impact on protein excretion in this model.At day 10 of anti-GBM disease, an increase in glomerular heparanase was shown using immunohistochemistry. Sequential staining studies revealed that this increase was associated with glomerular endothelial, epithelial cells and invading ED-1-positive inflammatory cells. RT-PCR revealed an insignificant 1.2-fold induction of mRNA at day 10 of disease. Western blot analysis of kidney cortex confirmed that the active 58-kDa heparanase species was restricted to diseased kidney at day 10. The inactive 65-kDa precursor, however, was found only in cortex derived from normal kidney. Proteinuria at day 10 of disease was significantly reduced, in the absence of altered rat anti-sheep antibody titres, after administration of a validated polyclonal anti-heparanase antibody (P < 0.05). Furthermore, sheep IgG deposition was not altered by administration of the anti-heparanase antibody.These data suggest that heparanase contributes to the pathogenesis of proteinuria in a model of anti-GBM disease.
Gov't Doc #: 15877677
DOI: 10.1111/j.1440-1797.2005.00388.x
Type: Journal Article
Subjects: Animals
Anti-Glomerular Basement Membrane Disease.enzymology.therapy
Blotting, Western
Disease Models, Animal
Gene Expression Regulation, Enzymologic
Glucuronidase.antagonists & inhibitors.genetics.immunology.metabolism
RNA, Messenger.analysis
Rats, Inbred WKY
Reverse Transcriptase Polymerase Chain Reaction
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 4, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.